Search for Clinical Trial Results

Sponsored By

Myelofibrosis - 47 Studies Found

Status Study
Active, not recruiting Study Name: Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis
Condition: Myelofibrosis
Date: 2013-03-14
Interventions:
  • Drug: A: Fludarabine + Busulphan

Completed Study Name: Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis
Condition: Myelofibrosis
Date: 2007-12-11
Interventions:
  • Drug: arsenic trioxide

Completed Study Name: A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis
Condition: Myelofibrosis
Date: 2017-02-27
Interventions:
  • Drug: Ruxolitinib Ruxolitinib

Completed Study Name: Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients
Condition: Myelofibrosis
Date: 2008-01-11
Interventions: Procedure: Allogeneic Stem Cell Transplantation Allogeneic Stem Cell Transplantation after dose-reduced
Completed Study Name: Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg
Condition: Myelofibrosis
Date: 2016-03-08
Interventions:
  • Drug: Ruxolotinib Ruxolitinib

Terminated Study Name: A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)
Condition: Primary Myelofibrosis
Date: 2014-03-06
Interventions: Drug: Ruxolitinib Starting dose was based on reason for previous discontinuation of ruxolitinib (i.e. lo
Completed Study Name: Thalidomide in Treating Patients With Myelofibrosis
Condition: Primary Myelofibrosis
Date: 2001-05-06
Interventions:
  • Drug: thalidomide Given PO
Withdrawn Study Name: A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Myelofibrosis
Condition: Primary Myelofibrosis
Date: 2015-10-21
Interventions: Biological: Pacritinib QD (Once a day)
Active, not recruiting Study Name: Decitabine in Treating Patients With Myelofibrosis
Condition:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    Date: 2004-11-09
    Interventions:
    • Drug: Decitabine Given SC
Recruiting Study Name: P1101 in Treating Patients With Myelofibrosis
Condition:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    Date: 2015-02-17
    Interventions:
    • Other: Laboratory Biomarker Analysis

<<< Previous | Next >>>